Laccase of Cryptococcus neoformans Is a Cell Wall-Associated Virulence Factor
暂无分享,去创建一个
[1] A. Casadevall,et al. Melanisation of Cryptococcus neoformans in human brain tissue , 2000, The Lancet.
[2] A. Casadevall,et al. Synthesis of Polymerized Melanin by Cryptococcus neoformans in Infected Rodents , 2000, Infection and Immunity.
[3] T. Brandhorst,et al. Cell Wall Biogenesis of Blastomyces dermatitidis , 2000, The Journal of Biological Chemistry.
[4] A. Casadevall,et al. Urease as a Virulence Factor in Experimental Cryptococcosis , 2000, Infection and Immunity.
[5] T. Brandhorst,et al. EVIDENCE FOR A NOVEL MECHANISM OF CELL SURFACE LOCALIZATION OF A VIRULENCE-ASSOCIATED ADHESIN VIA EXTRACELLULAR RELEASE AND REASSOCIATION WITH CELL WALL CHITIN* , 2000 .
[6] B. Wanke,et al. Possible primary ecological niche of Cryptococcus neoformans. , 2000, Medical mycology.
[7] P. Williamson,et al. Laccase Protects Cryptococcus neoformansfrom Antifungal Activity of Alveolar Macrophages , 1999, Infection and Immunity.
[8] W. Tanner,et al. Role of NaOH‐extractable cell wall proteins Ccw5p, Ccw6p, Ccw7p and Ccw8p (members of the Pir protein family) in stability of the Saccharomyces cerevisiae cell wall , 1999, Yeast.
[9] T. Harrison,et al. Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages , 1999, Infection and Immunity.
[10] K. Wakamatsu,et al. Catecholamine Oxidative Products, but Not Melanin, Are Produced by Cryptococcus neoformans during Neuropathogenesis in Mice , 1999, Infection and Immunity.
[11] K. Wakamatsu,et al. Melanin Biosynthesis in Cryptococcus neoformans , 1998, Journal of bacteriology.
[12] E. Hudson,et al. Development and applications of enhanced green fluorescent protein mutants. , 1998, BioTechniques.
[13] A. Casadevall,et al. Melanization of Cryptococcus neoformans in Murine Infection , 1998 .
[14] B. Reinhold,et al. Architecture of the Yeast Cell Wall , 1997, The Journal of Biological Chemistry.
[15] J. Heitman,et al. Calcineurin is required for virulence of Cryptococcus neoformans , 1997, The EMBO journal.
[16] T. Sorrell,et al. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? , 1997, The Journal of infectious diseases.
[17] E. Jacobson,et al. Ferric iron reduction by Cryptococcus neoformans , 1997, Infection and immunity.
[18] J. Perfect,et al. Dominant selection system for use in Cryptococcus neoformans. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[19] A. Casadevall,et al. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans , 1996, Infection and immunity.
[20] J. Kaplan,et al. Molecular biology of iron acquisition in Saccharomyces cerevisiae , 1996, Molecular microbiology.
[21] B. Wong,et al. Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. , 1996, Microbiology.
[22] L. Frontali,et al. The ‘petite‐negative’ yeast Kluyveromyces lactis has a single gene expressing pyruvate decarboxylase activity , 1996, Molecular microbiology.
[23] R. Wiesner,et al. Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy , 1995, Journal of neurochemistry.
[24] R. Pinner,et al. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] A. Casadevall,et al. Virulence: Mechanism of Action. Cryptococcus Neoformans Melanin And , 1995 .
[26] K. Kwon-Chung,et al. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence , 1994, Molecular and cellular biology.
[27] P. Williamson. Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase , 1994, Journal of bacteriology.
[28] T. Morita,et al. Characterization of a Phenol Oxidase from Cryptococcus neoformans var. neoformans , 1993, Microbiology and immunology.
[29] K. Kwon-Chung,et al. Rapid method to extract DNA from Cryptococcus neoformans , 1991, Journal of clinical microbiology.
[30] D Botstein,et al. Suppressors of yeast actin mutations. , 1989, Genetics.
[31] S. Emr,et al. Organelle assembly in yeast: characterization of yeast mutants defective in vacuolar biogenesis and protein sorting , 1988, The Journal of cell biology.
[32] T. Kozel,et al. Role of the capsule in phagocytosis of Cryptococcus neoformans. , 1988, Reviews of infectious diseases.
[33] T. Umezawa,et al. Degradation mechanisms of phenolic beta-1 lignin substructure model compounds by laccase of Coriolus versicolor. , 1988, Archives of biochemistry and biophysics.
[34] V. Hearing,et al. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans , 1982, Journal of bacteriology.
[35] D. Scheidegger,et al. Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.
[36] D. Tse,et al. Potential oxidative pathways of brain catecholamines. , 1976, Journal of medicinal chemistry.
[37] R. Tyndall,et al. Pigment production by Cryptococcus neoformans from para- and ortho-Diphenols: effect of the nitrogen source , 1975, Journal of clinical microbiology.
[38] F. Smith,et al. COLORIMETRIC METHOD FOR DETER-MINATION OF SUGAR AND RELATED SUBSTANCE , 1956 .
[39] A. L. Houwink,et al. Composition and Structure of Yeast Cell Walls , 1951, Nature.